Hormone Therapy May Help Women with Surgical Menopause Stay in Work Longer, Study Finds
Research shows hormone therapy can help women with surgical menopause remain employed longer, reducing early workforce exit risks. Source: https://medicalxpress.com/news/2025-10-women-surgical-menopause-exit-workforce.html
Recent research indicates that women who undergo surgical menopause—the removal of ovaries—may face a higher likelihood of leaving the workforce earlier than women who experience natural menopause. Early menopause, whether natural before 45 or surgical, is linked to increased health risks, including cardiovascular problems, osteoporosis, and intensified menopause symptoms such as hot flashes and depressive symptoms. These health issues can significantly impact women’s quality of life and ability to maintain employment.
A comprehensive study involving nearly 1,400 women analyzed how different menopause types influence career trajectories over a 10-year span, considering the role of hormone therapy as a mediating factor. The researchers employed employment history analysis to identify three distinct employment patterns and used regression models to examine how menopause timing and type affect workforce participation.
Findings revealed that women experiencing early natural menopause tend to have less flexibility in their work arrangements during this period, although they are not more likely to exit the workforce prematurely compared to women with later menopause. Conversely, those who underwent surgical menopause, especially women aged 45 or older at the time of surgery, were at a heightened risk of leaving their jobs earlier. Importantly, hormone therapy during the early postmenopause years was associated with a reduced risk of workforce exit for women with both early natural and surgical menopause.
The study emphasizes the importance of targeted workplace policies that recognize the diverse menopause experiences women go through. Dr. Stephanie Faubion, medical director at The Menopause Society, states that hormone therapy could be a valuable intervention to support women in maintaining their employment during and after menopause. Overall, these findings suggest that appropriate treatment and workplace accommodations could help mitigate the career impacts associated with early and surgical menopause.
Source: [https://medicalxpress.com/news/2025-10-women-surgical-menopause-exit-workforce.html]
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
The Spread of Red Meat Allergy Triggered by Tick Bites and the Role of Different Ticks in Alpha-Gal Syndrome
Alpha-gal syndrome is an increasingly common allergy triggered by tick bites, causing severe reactions to red meat and other mammalian products. This global spread involves multiple tick species, not just the lone star tick. Awareness and prevention are key to managing this emerging health concern.
Innovative Drug Targets Liver Tissue Structure to Combat Alcohol-Related Liver Damage
A novel cyclophilin inhibitor shows promise in reversing liver fibrosis caused by alcohol, using human tissue models to pave the way for new therapies in alcohol-related liver disease.
Emerging Advances in Obesity Treatment: Exploring Quintuple and Super Polyagonists for Better Weight Management
Innovative research on quintuple and super polyagonists offers new hope for more effective obesity and metabolic disorder treatments, combining multiple targets in a single molecule to enhance weight loss and glucose regulation.
